“…It is also an opportunistic pathogen in immunocompromised patients causing severe endophthalmitis, bacteremia, septicemia, endocarditis, pneumonia, meningitis, gastritis, and cutaneous infections (Senesi and Ghelardi, 2010); Vibrio bacteria is incriminated in mostly gastrointestinal and extra-intestinal diseases in man (Health protection agency, 2007); Enterococcus bacteria are common causes of nosocomial infections (Arias et al, 2010), such as catheter-associated urinary tract infections, endocarditis as well as surgical and burn wound infections (Abranches et al, 2013) ; E. coli bacteria, mostly the shiga toxin producing serotypes cause mild to bloody diarrhoea, haemorrhagic colitis, and hemolytic-uremic syndrome (HUS) (Brooks et al, 2005). Treatment of these various bacterial infections is, however, being hindered by the prevalence of antibiotic resistant strains (Furtula et al, 2013;Banerjee et al, 2013;Ghaima et al, 2013;Costa et al, 2014), and this therefore necessitates the need for newer and effective antimicrobials of which the before mentioned plant triterpenes offer a viable alternative considering their vast beneficial therapeutic potentials (Mosa et al, 2011;Machaba et al, 2014;Penduka et al, 2014).…”